View Post

Oral Antiviral Successfully Blocks SARS-CoV-2 Transmission

In COVID-19, Latest News by Precision Vaccinations

A new study found treating a SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours.
Researchers in the Institute for Biomedical Sciences at Georgia State University, led by Dr. Richard Plemper, Distinguished University Professor at Georgia State, originally discovered that the drug is potent against influenza viruses.

View Post

Air Industry Seeks to Abolish Passenger Quarantines

In Travel Vaccine News by Travel Vaccine

European and international aviation associations urge European governments to immediately abolish quarantine measures and other travel restrictions following new Recommendations published by the European Centre for Disease Prevention & Control (ECDC).
The European Union Aviation Safety Agency (EASA) – ECDC “Guidelines for COVID-19 testing and quarantine of air travelers: Addendum to the Aviation Health Safety Protocol” also confirm that air travelers account for less than 1 percent of all detected COVID-19 cases and do not increase the rate of virus transmission.

View Post

Plant-Based Dengue Virus Vaccine Identified

In COVID-19, Latest News by Precision Vaccinations

Researchers from the United Kingdom announced they used plants to produce virus-like particles (VLPs) of the dengue virus in a potential first step towards novel vaccines against the growing threat.
Led by Professor George Lomonossoff at the John Innes Centre in collaboration with Leaf Expression Systems published a pre-clinical study on October 25, 2020, which produced VLPs of dengue virus serotype 1, which is one of 4 serotypes of the virus.